A precursor of vitamin K may help slow down prostate cancer progression, a recent study conducted in mouse models of suggests ...

The prostate cancer patients were on average 63 (±6.3) years old at diagnosis ... Over 30% of patients classified as Gleason score six or less from the biopsy, were Gleason score seven or ...

Hormone therapy initiation depends on disease extent; some agents avoid testosterone flare, allowing ADT without Casodex in ...

Medically reviewed by Amelia MacIntyre, DO Approximately 1 in 8 people with a prostate are diagnosed with prostate cancer ...

Micrograph of prostate cancer with Gleason score 6 (3+3) (photo credit: Diagnostic Pathology 11/Jennifer Gordetsky and Jonathan Epstein) The Health Ministry in Jerusalem has just published data on ...

It was the holiday season, and although he felt mostly symptom-free, Michael Downer, a Kaiser Permanente Panorama City ...

How long you survive advanced prostate cancer can depend on the grade of your cancer cells (called the Gleason score ...

“The MMAI risk classifier is a more precise and accurate prognosticator of metastasis than NCCN risk groups,” Dr Tward’s team wrote. “This approach aims to prevent both overtreatment and ...

Men with stage T1 or T2 prostate cancer, a Gleason score of 3+4 or less ... was low for 8.4% of the patients and intermediate for 91.6%. At a median follow-up of 74.0 months, the 5-year incidence ...

1) OR: Odds Ratio derived from logistic regression considering as cases patients whose biopsy Gleason score was lower than the prostatectomy Gleason score and as controls everybody else ...